Form C/A — RS BioTherapeutics Inc.
0001665160-24-000900 · filed May 22, 2024
· via StartEngine Capital, LLC
https://rsbiotherapeutics.com
(possible website — auto-inferred, not verified)
Offering
- Target
- $10,000
- Maximum
- $1,235,000
- Security type
- Other
- Price per security
- —
- Deadline
- —
- Oversubscription
- Accepted
Issuer
- CIK
- 1932193
- Entity
- Corporation
- Jurisdiction
- DE
- Address
- 157 BALTIMORE ST. SUITE 140
CUMBERLAND, MD 21502 - Phone
- —
Most recent fiscal year financials
- Total assets
- $31,300
- Cash
- —
- Short-term debt
- $1,051,533
- Long-term debt
- $10,104
- Revenues
- —
- COGS
- —
- Taxes paid
- —
- Net income
- $-3,047,449
View the original filing on SEC EDGAR ↗